LAEKNA-B (02105) has issued a total of 273,000 shares to satisfy the vesting of RSUs granted under the 2024 Share Award Plan.
Lai Kai Pharmaceutical-B (02105) announced that on September 8, 2026, the company will issue a total of 273,000 ordinary shares to fulfill the vesting of RSUs granted under the 2024 Share Award Plan.
LAEKNA-B (02105) announced that on September 8, 2026, the company will issue a total of 273,000 common shares to fulfill the vesting of RSUs granted under the 2024 Share Incentive Plan.
Related Articles
Henan Yuneng Holdings (001896.SZ) plans to establish a subsidiary to invest in the construction of a 100MW wind power generation project.
Yili International (00585) appoints Jin Mingyi as Executive Director.
CHINASOFT INT'L (00354) has won the bid for the 35.5 million yuan pan-home open-source Harmony AI innovation center project. The "AI + open-source Harmony" strategy accelerates large-scale implementation.
Henan Yuneng Holdings (001896.SZ) plans to establish a subsidiary to invest in the construction of a 100MW wind power generation project.
Yili International (00585) appoints Jin Mingyi as Executive Director.
CHINASOFT INT'L (00354) has won the bid for the 35.5 million yuan pan-home open-source Harmony AI innovation center project. The "AI + open-source Harmony" strategy accelerates large-scale implementation.
RECOMMEND
